Filing Details
- Accession Number:
- 0000899243-17-017899
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-05 20:28:38
- Reporting Period:
- 2017-07-05
- Filing Date:
- 2017-07-05
- Accepted Time:
- 2017-07-05 20:28:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1420565 | Aileron Therapeutics Inc | ALRN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1657662 | Ltd. Kck | Omc Chambers Wickhams Cay1, Road Town Tortola D8 VG1110 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-07-05 | 446,817 | $0.00 | 446,817 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2017-07-05 | 200,000 | $15.00 | 646,817 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series E-3 Preferred Stock | Disposition | 2017-07-05 | 3,676,471 | $0.00 | 369,977 | $0.00 |
| Common Stock | Series F Preferred Stock | Disposition | 2017-07-05 | 763,552 | $0.00 | 76,839 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- The Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date.
Billionaire Hedge Funds
